Nogo-A: A useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion

Human Pathology

Volumn 43, Issue 3, 2012, Pages 374-380

  Marucci, Gianluca ^a   Di Oto, Enrico ^a   Farnedi, Anna ^a   Panzacchi, Riccardo ^a   Ligorio, Claudia ^a   Foschini, Maria P ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

1p 19q; FISH; Nogo A; Olig 2; Oligodendroglioma

Indexed keywords

BIOLOGICAL MARKER; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PROTEIN NOGO A; SYNAPTOPHYSIN;

ADULT; ARTICLE; ASTROCYTOMA; CHOROID PLEXUS PAPILLOMA; CHROMOSOME 1P; CHROMOSOME DELETION; CHROMOSOME IDENTIFICATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EPENDYMOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; NEUROEPITHELIOMA; OLIGODENDROGLIOMA; PILOCYTIC ASTROCYTOMA; PROTEIN EXPRESSION;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE DELETION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MYELIN PROTEINS; NERVE TISSUE PROTEINS; OLIGODENDROGLIOMA; PREDICTIVE VALUE OF TESTS; SYNAPTOPHYSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84857064904     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.05.007     Document Type: Article

References (28)

1. K. Aldape, M.L. Simmons, and R.L. Davis Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study Cancer 88 2000 2342 2349 (Pubitemid 30247135)
2. J.M. Bruner, L. Inouye, G.N. Fuller, and L.A. Langford Diagnostic discrepancies and their clinical impact in a neuropathology referral practice Cancer 79 1997 796 803 (Pubitemid 27076346)
3. S.W. Coons, P.C. Johnson, B.W. Scheithauer, A.J. Yates, and D.K. Pearl Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas Cancer 79 1997 1381 1393 (Pubitemid 27143246)
4. Y. Nakagawa, E. Perentes, and L. Rubinstein Immunohistochemical characterization of oligodendrogliomas: an analysis of multiple markers Acta Neuropathol 72 1986 15 22 (Pubitemid 17232763)
5. M. Preusser, A. Lehotzky, H. Budka, J. Ovádi, and G.G. Kovács TPPP/p25 in brain tumours: expression in non-neoplastic oligodendrocytes but not in oligodendroglioma cells Acta Neuropathol 113 2007 213 215
6. D.N. Louis, H. Ohgaki, O.D. Wiestler, and W.K. Cavenee WHO classification of tumours of the central nervous system 2007 IARC Lyon
7. M. Preusser, U. Laggner, C. Haberler, H. Heinzl, H. Budka, and J.A. Hainfellner Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology Histopathology 48 2006 438 444
8. F. Giangaspero, G. Cenacchi, L. Losi, S. Cerasoli, M. Bisceglia, and P.C. Burger Extraventricular neoplasms with neurocytoma features. A clinicopathological study of 11 cases Am J Surg Pathol 21 1997 206 212 (Pubitemid 27084061)
9. S.B. Wharton, K.K. Chan, F.A. Hamilton, and J.R. Anderson Expression of neuronal markers in oligodendrogliomas: an immunohistochemical study Neuropathol Appl Neurobiol 24 1998 302 308 (Pubitemid 28389127)
10. M. Vyberg, B.P. Ulhøi, and P.S. Teglbjaerg Neuronal features of oligodendrogliomas-an ultrastructural and immunohistochemical study Histopathology 50 2007 887 896 (Pubitemid 46850061)
11. Y. Marie, M. Sanson, and K. Mokhtari OLIG2 as a specific marker of oligodendroglial tumour cells Lancet 358 2001 298 300 (Pubitemid 32738972)
12. T. Kuhlmann, A. Gutenberg, H.J. Schulten, W. Paulus, V. Rohde, and W. Bruck Nogo-A expression in glial CNS tumors. A tool to differentiate between oligodendrogliomas and other gliomas Am J Surg Pathol 32 2008 1444 1453
13. T.Y. Jung, S. Jung, and K.H. Lee Nogo-A expression in oligodendroglial tumors Neuropathology 31 2011 11 19
14. X. Wang, S.J. Chun, H. Treloar, T. Vartanian, C.A. Greer, and S.M. Strittmatter Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact J Neurosci 22 2002 5505 5515 (Pubitemid 35386472)
15. J.E. Kim, S. Li, T. GrandPre, D. Qiu, and S.M. Strittmatter Axon regeneration in young adult mice lacking Nogo-A/B Neuron 38 2003 187 199 (Pubitemid 36555646)
16. K.B. Fallon, C.A. Palmer, and K.A. Roth Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas J Neuropathol Exp Neurol 63 2004 314 322 (Pubitemid 38429028)
17. R.B. Jenkins, H. Blair, and K.V. Ballman A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma Cancer Res 66 2006 9852 9861 (Pubitemid 44672036)
18. C.A. Griffin, P. Burger, and L. Morsberger Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss J Neuropathol Exp Neurol 65 2006 988 994 (Pubitemid 44521799)
19. F. Ducray, S. El Hallani, and A. Idbaih Diagnostic and prognostic markers in gliomas Curr Opin Oncol 21 2009 537 542
20. J.S. Smith, A. Perry, and T.J. Borell Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas J Clin Oncol 18 2000 636 645 (Pubitemid 30078545)
21. K.L. Ligon, J.A. Alberta, and A.T. Kho The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas J Neuropathol Exp Neurol 63 2004 499 509 (Pubitemid 38669670)
22. K. Mokhtari, S. Paris, and L. Aguirre-Cruz Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification Neuropathol Appl Neurobiol 31 2005 62 69 (Pubitemid 40222826)
23. M.D. Johnson, C.L. Vnencak-Jones, S.A. Toms, P.M. Moots, and R. Weil Allelic losses in oligodendroglial and oligodendroglioma-like neoplasms: analysis using microsatellite repeats and polymerase chain reaction Arch Pathol Lab Med 127 2003 1573 1579 (Pubitemid 37517467)
24. R.A. Prayson, E.A. Castilla, M. Hartke, J. Pettay, R.R. Tubbs, and G.H. Barnett Chromosome 1p allelic loss by fluorescence in situ hybridization is not observed in dysembryoplastic neuroepithelial tumors Am J Clin Pathol 118 2002 512 517 (Pubitemid 44698507)
25. K. Aldape, P.C. Burger, and A. Perry Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendroglioma Arch Pathol Lab Med 131 2007 242 251
26. Y. Ino, R.A. Betensky, and M.C. Zlatescu Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis Clin Cancer Res 7 2001 839 845 (Pubitemid 32708719)
27. M. Preusser, R. Charles Janzer, and J. Felsberg Anti-O6-methylguanine- methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker Brain Pathol 18 2008 520 532
28. L. Karayan-Tapon, V. Quillien, and J. Guilhot Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods J Neurooncol 97 2010 311 322